Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

We provide a methodology for selecting high-growth dividend stocks, focusing on dividend growth and sustainability rather ...

Today, companies across sectors including DLF, Pfizer, Zydus Wellness, One Mobikwik Systems, Restaurant Brands Asia, Bharat ...

NBCC: The company has successfully sold 446 residential units at Aspire Silicon City in Noida through an e-auction, generating Rs 1,468 crore in sales. Additionally, it will receive a marketing fee of ...

Foreign portfolio investors remained net buyers of Indian equities for the third straight day on Friday, as they mopped up equities worth Rs 8,831.1 crore, the highest since March 27, according to the ...

Shares of Pfizer Ltd are in news today rose after the firm reported a stellar set of Q4 earnings. The pharma firm reported a ...

At Pfizer's share price at the time of this writing ($22.87), you'd need to invest roughly $132,966 to generate $10,000 in ...

Pfizer stated that the drug candidate, which is being evaluated for non-small cell lung cancer, metastatic colorectal cancer ...

Pfizer also plans to make a $100 million equity investment in the Chinese biotechnolgoy company after the transaction closes, ...

Pfizer share price gained 13% in the intraday trades on Tuesday post Q4 Results, dividend announcement and despite stock ...